Genentech, Inc. (JOBS) Revises Rituxan Warning After Death

WASHINGTON, Sept 11 (Reuters) - Genentech Inc has revised a warning on the drug Rituxan to reflect the case of a rheumatoid arthritis patient, who was treated with the medicine and died from a brain infection, U.S. health officials said on Thursday.

Back to news